France Heart Pump Device Market Insight
Published: 19 May 2026 | Report Format: Electronic (PDF)
The France Heart Pump Device market size is growing at a 8.1% CAGR, by increasing heart failure incidence, rising aging population, expanding adoption of advanced cardiac surgeries, and growing investments in critical care and cardiovascular treatment technologies
France Heart Pump Device Market Insights Forecasts to 2035
- The France Heart Pump Device Market Size Was Estimated at USD 352.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.1% from 2025 to 2035
- The France Heart Pump Device Market Size is Expected to Reach USD 768 Million by 2035
Notable Insights for France Heart Pump Device Market
- The ventricular assist devices segment dominates the France heart pump device market and generated approximately USD 178 million in revenue during 2025. Rising advanced heart failure treatment demand continues supporting segment growth.
- The bridge-to-transplant therapy segment is expected to witness strong growth during the forecast period with an estimated CAGR of 9%, supported by increasing heart transplant waiting lists and advanced cardiac support adoption.
- Approximately 50% of total market revenue in France is generated by ventricular assist devices, supporting advanced cardiac failure management extensively.
- Nearly 55% of market demand comes from hospitals and cardiac surgery centers, increasing mechanical circulatory support adoption steadily nationwide
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Heart Pump Device market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Heart Pump Device Market
- Abbott Laboratories
- Medtronic
- Abiomed
- Berlin Heart
- LivaNova
- Getinge
- SynCardia Systems
- Terumo Corporation
- Jarvik Heart
- Fresenius Medical Care
- Others
Recent Developments:
- In April 2026, Abbott Laboratories expanded its next-generation ventricular assist device portfolio with advanced remote monitoring capabilities, helping cardiac specialists improve patient management, optimize long-term heart failure treatment outcomes, and support minimally invasive cardiovascular care strategies across France.
Market Segmentation:
France Heart Pump Device Market, By Product Type
- Ventricular Assist Devices (VADs)
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Total Artificial Hearts
- Others
France Heart Pump Device Market, By Application
- Heart Failure Treatment
- Cardiogenic Shock Management
- Bridge-to-Transplant Therapy
- Destination Therapy
- Others
France Heart Pump Device Market, By End-User
- Hospitals
- Cardiac Surgery Centers
- Specialty Clinics
- Research Institutes
- Others
Expert Views:
The France heart pump device market will keep on expanding steadily, mainly because the cardiovascular disease burden is climbing, more hospitals are adopting advanced cardiac support technologies, and there’s growing funding for specialized heart failure treatment infrastructure. In the next phase, market growth should be pushed along by AI driven cardiac monitoring systems, some portable ventricular assist device innovation, plus minimally invasive circulatory support technologies. Also, the expansion of advanced cardiac surgery programs will matter, and so will the increasing adoption of personalized cardiovascular treatment solutions across France.
Author: Sanket and Pranali By Spherical Insights and Consulting